Junyu Xu

A First-in-Human Trial of GLS4, a Novel Inhibitor of Hepatitis B Virus Capsid Assembly, following Single- and Multiple-Ascending-Oral-Dose Studies with or without Ritonavir in Healthy Adult Volunteers

Nan Zhao, Bo Jia, Hong Zhao et al. · Antimicrobial Agents and Chemotherapy · 2019 · 45 citations · Full text

Healthy Adult Volunteers, First-in-human Trial, Antiviral Compound +15

Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients

Zhiqi Wang, Nan Zhang, Chaoyang Chen et al. · Current Drug Metabolism · 2019 · 23 citations · Full text

Causal association between body mass index and temporomandibular disorders: a bidirectional two-sample Mendelian randomization analysis

Xin Chen, Cheng Zheng, Junyu Xu et al. · BMC Oral Health · 2023 · 11 citations · Full text

Photodetection and Safety of 5‐Aminolevulinic Acid‐Induced Porphyrin in Patients With Cervical Intraepithelial Neoplasia

Junyu Xu, Jian Zhao, Ying Dong et al. · Lasers in Surgery and Medicine · 2020 · 10 citations

Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study

Junyu Xu, Yifei Zhang, Yiming Li et al. · Advances in Therapy · 2021 · 10 citations

Chinese Healthy Subjects, Multiple Doses, Medicine +4